Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

BeyondSpring submits patent application for BPI-002 as antiviral treatment

March 13, 2020

Sunshine Lake Pharma discovers HBsAg inhibitors for HBV infections

March 12, 2020

Tiziana accelerates development of TZLS-501 for COVID-19

March 11, 2020

Brilacidin to be tested against COVID-19

March 11, 2020

Decoy exosomes fight bacterial toxin

March 11, 2020

Ascletis offers update on Chinese trial of Ganovo and ritonavir for novel coronavirus pneumonia

March 10, 2020

AbbVie partners with global authorities to evaluate HIV drug for treatment of COVID-19

March 10, 2020

CEL-SCI applies its LEAPS peptide technology to develop immunotherapy against COVID-19

March 10, 2020

Algernon makes ifenprodil available for compassionate use for coronavirus

March 9, 2020

CytoDyn submits IND application to study leronlimab for COVID-19 respiratory complications

March 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...